If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.59    -0.02 (-0.77%)
Bid:
2.58
Ask:
2.595
Spread: 0.015 (0.581%)
Market Cap: $8.55b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB Consolidated Interim Condensed June Statements

14 Jul 2020 07:00

RNS Number : 8814S
Commercial Intnl Bank (Egypt) SAE
14 July 2020
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial International Bank (Egypt) S.A.E.

Condensed Consolidated Interim Financial Statements

June 30, 2020 

Click on, or paste the following link into your web browser, to view the associated PDF document. 

http://www.rns-pdf.londonstockexchange.com/rns/8814S_1-2020-7-13.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated condensed Interim balance sheet as at June 30, 2020

 

 

 

 

 

 

 

 

 

 

Notes

 

 

Jun. 30, 2020

 

 

 

Dec. 31, 2019

 

 

 

 

EGP Thousands

 

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Cash and balances with central bank

7

 

 

 31,267,392

 

 

 

28,273,962

Due from banks

8

 

 

 56,949,232

 

 

 

28,353,366

Loans and advances to banks, net

10

 

 

 883,248

 

 

 

625,264

Loans and advances to customers, net

11

 

 

 120,030,212

 

 

 

119,321,103

Derivative financial instruments

 

 

 

 315,916

 

 

 

216,383

Investments

 

 

 

 

 

 

 

 

 

- Financial Assets at Fair value through P&L

 

12

 

 

 357,304

 

 

 

418,781

- Financial Assets at Fair value through OCI

 

12

 

 

 85,100,258

 

 

 

89,897,257

- Amortized cost

 

12

 

 

 92,972,929

 

 

 

107,225,613

- Investments in associates

13

 

 

 99,837

 

 

 

107,693

Other assets

 

 

 

 9,009,198

 

 

 

9,748,143

Goodwill

22

 

 

 243,046

 

 

 

-

Deferred tax assets (Liabilities)

 

 

 

 457,940

 

 

 

350,339

Property, plant and equipment

14

 

 

 2,363,886

 

 

 

2,204,464

Total assets

 

 

 

 400,050,398

 

 

 

386,742,368

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Due to banks

15

 

 

 12,277,482

 

 

 

11,810,607

Due to customers

16

 

 

 320,146,441

 

 

 

304,448,455

Derivative financial instruments

 

 

 

 340,652

 

 

 

282,588

Current tax liabilities

 

 

 

 2,652,208

 

 

 

4,639,364

Other liabilities

 

 

 

 5,450,289

 

 

 

8,396,794

Other loans

 

 

 

 3,250,254

 

 

 

3,272,746

Provisions

17

 

 

 3,069,002

 

 

 

2,011,369

Total liabilities

 

 

 

 347,186,328

 

 

 

334,861,923

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

Issued and paid up capital

 

 

 

 14,690,821

 

 

 

 14,690,821

Reserves

 

 

 

 31,328,841

 

 

 

 24,344,815

Reserve for employee stock ownership plan (ESOP)

 

 

 

 1,260,111

 

 

 

 963,152

Retained earnings *

 

 

 

 5,131,049

 

 

 

 11,881,657

Total equity

 

 

 

 52,410,822

 

 

 

 51,880,445

Minority interest

 

 

 

453,248

 

 

 

 -

Total minority interest, equity and net profit for the period/year

 

 

 

 52,864,070

 

 

 

 51,880,445

Total liabilities and equity

 

 

 

400,050,398

 

 

 

 386,742,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

 

 

(Review report attached)

 

 

 

 

 

 

 

 

*Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hisham Ezz Al-Arab

 

 

 

 

Chairman and Managing Director

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated condensed Interim income statement for the period ended June 30, 2020

 

 

 

 

 

 

 

 

 

 

 

Note

Jun. 30, 2020

 

 

Jun. 30, 2019

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

Continued Operations

 

 

 

 

 

 

Interest and similar income

 

 

20,922,642

 

 

20,695,803

Interest and similar expense

 

 

(8,445,315)

 

 

(10,690,088)

Net interest income

 

 

12,477,327

 

 

10,005,715

 

 

 

 

 

 

 

Fee and commission income

 

 

1,479,217

 

 

1,647,254

Fee and commission expense

 

 

(493,057)

 

 

(536,140)

Net fee and commission income

 

 

986,160

 

 

1,111,114

 

 

 

 

 

 

 

Dividend income

 

 

25,962

 

 

22,454

Net trading income

 

5

177,231

 

 

379,943

Profits (Losses) on financial investments

 

12

832,005

 

 

19,781

Administrative expenses

 

 

(2,848,020)

 

 

(2,619,234)

Other operating (expenses) income

 

 

(1,847,212)

 

 

(662,508)

Goodwill amortization

 

 

(8,381)

 

 

-

Intangible assets amortization

 

 

-

 

 

(65,104)

Impairment release (charges) for credit losses

 

 

(2,259,654)

 

 

(795,124)

Bank's share in the profits of associates

 

 

6,994

 

 

(1,101)

Profit before income tax

 

 

7,542,412

 

 

7,395,936

 

 

 

 

 

 

 

Income tax expense

 

 

(2,652,208)

 

 

(2,058,736)

Deferred tax assets (Liabilities)

 

 

107,601

 

 

17,300

Net profit for the period

 

 

4,997,805

 

 

5,354,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earning per share

 

6

 

 

 

 

Basic

 

 

3.01

 

 

3.23

Diluted

 

 

3.00

 

 

3.21

 

 

 

 

 

 

 

 

 

 

 

 

 

Hisham Ezz Al-Arab

 

 

 

 

 

Chairman and Managing Director

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of other Comprehensive Income for the period ended June 30, 2020

 

 

 

Last 6 Months

 

Last 6 Months

 

 

 

 

 

 

 

 

 

Jun. 30, 2020

 

Jun. 30, 2019

 

 

 

 

 

 

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit for the period

 

 

4,997,805

 

5,354,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in fair value of instruments measured at fair value through other comprehensive income

 

 

(1,483,581)

 

2,838,861

 

 

 

 

 

 

Cumulative foreign currencies translation differences

 

 

1,647

 

4,182

 

 

 

 

 

 

Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income

 

 

90,512

 

(109,668)

 

 

 

 

 

 

Total other comprehensive income for the period

 

 

3,606,383

 

8,087,875

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended June 30, 2020

 

 

 

 

 

 

Notes

Jun. 30, 2020

 

Jun. 30, 2019

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax from continued operations

 

7,542,412

 

7,395,936

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

14

383,782

 

275,052

Impairment charge for credit losses (Loans and advances to customers and banks)

 

2,144,988

 

875,635

Other provisions charges

17

1,098,888

 

3,140

Impairment charge for credit losses (due from banks)

 

24,154

 

29,156

Impairment charge for credit losses (financial investments)

 

90,512

 

(109,667)

Impairment charge for other assets

 

24,621

 

52,772

Exchange revaluation differences for financial assets at fair value through OCI

 

(84,884)

 

886,795

Goodwill amortization

 

8,381

 

-

Intangible assets amortization

 

-

 

65,104

Impairment charge financial assets at fair value through OCI

 

-

 

45,664

Exchange differences in financial investments in subsidiary

 

-

 

3,020

Utilization of other provisions

17

(1,066)

 

1,878

Other provisions no longer used

17

(43,200)

 

(126,575)

Exchange differences of other provisions

17

3,011

 

(69,724)

Profits from selling property, plant and equipment

 

(94)

 

(1,439)

(Profits) losses from selling financial investments

12

(924,720)

 

(65,445)

Released (Impairment) charges of investments in associates and subsidiaries

0

14,100

 

-

Shares based payments

 

296,959

 

247,998

Bank's share in the profits of associates

 

(6,994)

 

1,101

Released (Impairment) charges of FVOCI equity instruments

 

78,615

 

-

Operating profits before changes in operating assets and liabilities

 

10,649,465

 

9,510,401

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

8

(598,148)

 

(25,049,337)

Treasury bills and other governmental notes

 

280,433

 

24,315,394

Financial assets at fair value through P&L

12

61,477

 

2,262,513

Derivative financial instruments

 

(41,469)

 

(75,592)

Loans and advances to banks and customers

10 - 11

(3,109,801)

 

(4,776,117)

Other assets

 

907,956

 

1,289,326

Due to banks

15

466,875

 

(5,879,606)

Due to customers

16

15,697,986

 

20,265,649

Income tax obligations paid

 

(4,639,364)

 

(3,625,579)

Other liabilities

 

(2,946,225)

 

(1,225,572)

Net cash provided from operating activities

 

16,729,185

 

17,011,480

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds from Investments in associates.

 

750

 

-

Proceeds (payments) for investment in subsidiaries.

 

194,722

 

-

Payment for purchases of property, plant, equipment and branches constructions

 

(739,117)

 

(840,953)

Proceeds from selling property, plant and equipment

 

94

 

1,439

Proceeds from redemption of financial assets at amortized cost

 

59,360,102

 

33,290,053

Payment for purchases of financial assets at amortized cost

 

(44,945,839)

 

(32,633,462)

Payment for purchases of financial assets at fair value through OCI

 

(50,868,698)

 

(11,433,512)

Proceeds from selling financial assets at fair value through OCI

 

55,237,128

 

5,105,870

Net cash used in investing activities

 

18,239,142

 

(6,510,565)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Increase (decrease) in long term loans

 

(22,492)

 

(230,801)

Dividend paid

 

(3,370,464)

 

(2,700,544)

Net cash used in (provided from) financing activities

 

(3,392,956)

 

(2,931,345)

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the period

 

31,575,371

 

7,569,570

Beginning balance of cash and cash equivalent

 

22,895,017

 

34,303,645

Cash and cash equivalent at the end of the period

 

54,470,388

 

41,873,215

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances with central bank

7

31,267,392

 

24,993,377

Due from banks

8

56,990,499

 

66,543,158

Treasury bills and other governmental notes

9

27,586,282

 

25,344,096

Obligatory reserve balance with CBE

7

(22,995,458)

 

(15,980,212)

Due from banks with maturities more than three months

 

(10,266,783)

 

(33,329,274)

Treasury bills with maturity more than three months

 

(28,111,544)

 

(25,697,930)

Total cash and cash equivalent

 

54,470,388

 

41,873,215

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated condensed Interim statement of changes in shareholders' equity for the period ended June 30, 2019

 

 

 

 

 

 

 

 

 

 

Jun. 30, 2019

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

11,668,326

1,710,293

12,776,215

1,549,445

12,421

(1,860,851)

4,323

9,637,083

738,320

-

36,235,575

-

36,235,575

Capital increase

2,917,082

-

(2,917,082)

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

477,736

6,375,589

-

1,045

-

-

(6,854,370)

-

-

-

-

-

Dividend paid

-

-

-

-

-

-

-

(2,700,544)

-

-

(2,700,544)

-

(2,700,544)

Net profit of the period

-

-

-

-

-

-

-

5,354,500

-

-

5,354,500

-

5,354,500

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

2,838,861

-

-

-

-

2,838,861

-

2,838,861

Transferred (from) to bank risk reserve

-

-

-

-

-

-

841

(841)

-

-

-

-

-

ECL for impairment of debt instruments investments

-

-

-

-

-

(109,668)

-

-

-

-

(109,668)

-

(109,668)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

247,998

-

247,998

-

247,998

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

4,182

4,182

-

4,182

Balance at the end of the period

14,585,408

2,188,029

16,234,722

1,549,445

13,466

868,342

5,164

5,435,828

986,318

4,182

41,870,904

-

41,870,904

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated condensed Interim statement of changes in shareholders' equity for the period ended June 20, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Jun. 30, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,881,657

963,152

2,501

51,880,445

-

51,880,445

Capital increase

-

-

-

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

590,106

7,840,286

-

1,440

-

-

(8,431,832)

-

-

-

-

-

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

-

(3,370,464)

-

(3,370,464)

Minority Interest share

-

-

-

-

-

-

-

-

-

-

-

453,248

453,248

Net profit of the period

-

-

-

-

-

-

-

4,997,805

-

-

4,997,805

-

4,997,805

Transferred from reserve for financial assets at fair value through OCI

-

-

-

-

-

(55,142)

-

55,142

-

-

-

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(1,483,581)

-

-

-

-

(1,483,581)

-

(1,483,581)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

-

-

-

Release provision for impairment of debt instruments investments

-

-

-

-

-

90,512

-

-

-

-

90,512

-

90,512

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

296,959

-

296,959

-

296,959

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

(854)

(854)

-

(854)

Balance at the end of the period

14,690,821

2,778,135

24,314,715

1,549,445

14,906

2,663,570

6,423

5,131,049

1,260,111

1,647

52,410,822

453,248

52,864,070

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR EAEXDFEFEEAA
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.